Novel adenosine A3 receptor agonists

Details for Australian Patent Application No. 2004274475 (hide)

Owner King Pharmaceuticals Research & Development, Inc.

Inventors Borea, Pier A.; Baraldi, Pier Giovanni; Moorman, Allan R.

Agent Pizzeys

Pub. Number AU-B-2004274475

PCT Pub. Number WO2005/028489

Priority 60/504,579 18.09.03 US

Filing date 17 September 2004

Wipo publication date 31 March 2005

Acceptance publication date 6 August 2009

International Classifications

A61K 31/70 (2006.01) - Carbohydrates

A01N 43/90 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds - having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system

A61K 31/7076 (2006.01)

C07H 1/00 (2006.01) Processes for the preparation of sugar derivatives

C07H 19/16 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

Event Publications

30 March 2006 PCT application entered the National Phase

  PCT publication WO2005/028489 Priority application(s): WO2005/028489

6 August 2009 Application Accepted

  Published as AU-B-2004274475

3 December 2009 Standard Patent Sealed

14 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004274480-Fused pentacyclic polyethers

2004274474-Thalidomide analogs as TNF-alpha modulators